Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3034241rdf:typepubmed:Citationlld:pubmed
pubmed-article:3034241lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:3034241lifeskim:mentionsumls-concept:C0018026lld:lifeskim
pubmed-article:3034241lifeskim:mentionsumls-concept:C0036140lld:lifeskim
pubmed-article:3034241lifeskim:mentionsumls-concept:C0172956lld:lifeskim
pubmed-article:3034241lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:3034241lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:3034241pubmed:issue1lld:pubmed
pubmed-article:3034241pubmed:dateCreated1987-5-28lld:pubmed
pubmed-article:3034241pubmed:abstractTextSix gold(I) salts, some of which are used as drugs in chrysotherapy, are shown to be inhibitors of two forms of human neutrophil collagenase. The IC50 values vary over six orders of magnitude, the lowest being 3.5 nM for Myocrisin. Thus, inhibition is greatly affected by the identity of the ligands to the gold(I) atom. The inhibition of collagenase by these gold(I) salts may be a partial basis for their antiarthritic action.lld:pubmed
pubmed-article:3034241pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3034241pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3034241pubmed:languageenglld:pubmed
pubmed-article:3034241pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3034241pubmed:citationSubsetIMlld:pubmed
pubmed-article:3034241pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3034241pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3034241pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3034241pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3034241pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3034241pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3034241pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3034241pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3034241pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3034241pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3034241pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3034241pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3034241pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3034241pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3034241pubmed:statusMEDLINElld:pubmed
pubmed-article:3034241pubmed:monthAprlld:pubmed
pubmed-article:3034241pubmed:issn0006-291Xlld:pubmed
pubmed-article:3034241pubmed:authorpubmed-author:Van WartH EHElld:pubmed
pubmed-article:3034241pubmed:authorpubmed-author:MallyaS KSKlld:pubmed
pubmed-article:3034241pubmed:issnTypePrintlld:pubmed
pubmed-article:3034241pubmed:day14lld:pubmed
pubmed-article:3034241pubmed:volume144lld:pubmed
pubmed-article:3034241pubmed:ownerNLMlld:pubmed
pubmed-article:3034241pubmed:authorsCompleteYlld:pubmed
pubmed-article:3034241pubmed:pagination101-8lld:pubmed
pubmed-article:3034241pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:3034241pubmed:meshHeadingpubmed-meshheading:3034241-...lld:pubmed
pubmed-article:3034241pubmed:meshHeadingpubmed-meshheading:3034241-...lld:pubmed
pubmed-article:3034241pubmed:meshHeadingpubmed-meshheading:3034241-...lld:pubmed
pubmed-article:3034241pubmed:meshHeadingpubmed-meshheading:3034241-...lld:pubmed
pubmed-article:3034241pubmed:meshHeadingpubmed-meshheading:3034241-...lld:pubmed
pubmed-article:3034241pubmed:meshHeadingpubmed-meshheading:3034241-...lld:pubmed
pubmed-article:3034241pubmed:meshHeadingpubmed-meshheading:3034241-...lld:pubmed
pubmed-article:3034241pubmed:meshHeadingpubmed-meshheading:3034241-...lld:pubmed
pubmed-article:3034241pubmed:meshHeadingpubmed-meshheading:3034241-...lld:pubmed
pubmed-article:3034241pubmed:meshHeadingpubmed-meshheading:3034241-...lld:pubmed
pubmed-article:3034241pubmed:meshHeadingpubmed-meshheading:3034241-...lld:pubmed
pubmed-article:3034241pubmed:meshHeadingpubmed-meshheading:3034241-...lld:pubmed
pubmed-article:3034241pubmed:meshHeadingpubmed-meshheading:3034241-...lld:pubmed
pubmed-article:3034241pubmed:meshHeadingpubmed-meshheading:3034241-...lld:pubmed
pubmed-article:3034241pubmed:meshHeadingpubmed-meshheading:3034241-...lld:pubmed
pubmed-article:3034241pubmed:year1987lld:pubmed
pubmed-article:3034241pubmed:articleTitleInhibition of human neutrophil collagenase by gold(I) salts used in chrysotherapy.lld:pubmed
pubmed-article:3034241pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3034241pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:3034241pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed